Beta-Blocker Tx Attenuates Prognostic Value of ppMHR

Share this content:
Beta-Blocker Tx Attenuates Prognostic Value of ppMHR
Beta-Blocker Tx Attenuates Prognostic Value of ppMHR

TUESDAY, Nov. 22, 2016 (HealthDay News) -- The prognostic value of lower heart rate thresholds (defined as the percentage of age-predicted maximal heart rate achieved, or ppMHR) is attenuated for patients on beta-blocker therapy (BBT), according to a study published in the Dec. 1 issue of The American Journal of Cardiology.

Rupert K. Hung, M.D., from the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease in Baltimore, and colleagues conducted a retrospective cohort study involving 64,549 adults without congestive heart failure or atrial fibrillation who underwent clinician-referred exercise stress testing, with median follow-up of 10.6 years. The authors examined the effect of BBT, ppMHR, and estimated exercise capacity on mortality.

The researchers identified 9,259 deaths during follow-up. BBT correlated with an 8 percent lower adjusted achieved ppMHR (91 versus 83 percent for no BBT versus BBT). There was an inverse correlation for ppMHR with all-cause mortality, with significant attenuation by BBT (per 10 percent ppMHR, hazard ratio: no BBT, 0.80 versus BBT, 0.89). The adjusted mortality rate was similar for patients on BBT who achieved 65 percent ppMHR versus those not on BBT who achieved 85 percent ppMHR. The prognostic value of ppMHR was further attenuated by estimated exercise capacity (per 10 percent ppMHR, hazard ratio: no BBT, 0.88 versus BBT, 0.95).

"In conclusion, the prognostic value of ppMHR was significantly attenuated by BBT," the authors write. "For patients on BBT, a lower threshold of 65 percent ppMHR may be considered for determining worsened prognosis."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »